Document
30day notice
ICR 202609-0925-001 · OMB 0925-0698 · Object 174228200.
Document Viewer [pdf]
Status: Original and derived artifacts are available for this document.
Download: pdf
Loading document viewer…
Document Metadata
| File Type | application/pdf |
|---|---|
| File Title | 30day notice |
| Last Modified By | govinfo, U. S. Government Publishing Office |
| File Modified | 2026-10-27 |
| File Created | 2026-10-27 |
| Conversion State | complete |
Extracted Text
67592 Federal Register / Vol. 91, No. 206 / Tuesday, October 27, 2026 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued Form No. Form name 5 ........ OPTN Ad hoc Conflict-of-Interest Disclosure Questionnaire ** +. OPTN Attestation Form ...................................................... OPTN Code of Conduct Form ........................................... OPTN Volunteer Confidentiality Agreement + .................... Total ............................................................................ 6 ........ 7 ........ 8 ........ Number of respondents Number of responses per respondent Total responses Average burden per response (in hours) 74 24 1,776 0.08 142.08 505 1,346 1,346 1 1 1 505 1,346 1,346 0.08 0.08 0.08 40.40 107.68 107.68 5,833 ........................ 7,683 .................... 2,110.84 Total burden hours * Estimated responses per year, every 2-to-3 years. ** Board members submit ad hoc conflict-of-interest forms prior to each monthly meeting, and before any ad hoc Board Meeting or Executive Board meeting with specific institution-based discussion. + Form name has been updated since the publication of the 60-day Federal Register Notice. Amy P. McNulty, Deputy Director, Executive Secretariat. [FR Doc. 2026–21857 Filed 10–26–26; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings lotter on DSK8BHNXB4PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Neurosensory Systems. Date: November 23–24, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. ADDRESS: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Li Jia, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–8068, [email protected]. Name of Committee: Center for Scientific Review, Special Emphasis Panel; RFA Panel: Cardiovascular Science. Date: November 23, 2026. Time: 9:30 a.m. to 1:00 p.m. VerDate Sep<11>2014 17:59 Oct 26, 2026 Jkt 271001 Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Nawazish Ali Naqvi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827–7911, nawazish.naqvi@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cognitive and Language Habilitation and Rehabilitation. Date: November 23–24, 2026. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Devon Rene Oskvig, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–9088, devon.oskvig@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Training and Career Development: Epidemiology and Population Health. Date: November 24, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Magnus A. Azuine, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435–7579, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Interdisciplinary fields of Bioengineering, Imaging and Vascular Sciences. Date: November 24, 2026. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827–7085, zhihong.shan@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 23, 2026. Margaret N. Vardanian, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2026–21903 Filed 10–26–26; 8:45 am] BILLING CODE 4167–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research AGENCY: National Institutes of Health, HHS. ACTION: Notice. SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received by November 27, 2026. E:\FR\FM\27OCN1.SGM 27OCN1 67593 Federal Register / Vol. 91, No. 206 / Tuesday, October 27, 2026 / Notices FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, contact: Tom Burklow, MD, Office of Clinical Research Training and Medical Education, NIH Clinical Center, National Institutes of Health, 10 Center Drive, Room 1N262, Bethesda, MD 20892–1158, or call non-toll-free number 301–435–8015, or email your request, including your address to: [email protected]. Formal requests for additional plans and instruments must be requested in writing. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on August 6, 2026, page 50864 (Vol. 91, No. 450) and allowed 60 days for public comment. No comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The Clinical Center, National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. Proposed Collection Title: Application Process for Clinical Research Training and Medical Education at the NIH Clinical Center and Its impact on Course and Training Program Enrollment and Effectiveness, 0925–0698, REVISION, Exp., date October 31, 2026, National Institutes of Health Clinical Center (CC), National Institutes of Health (NIH). Need and Use of Information Collection: The primary objective of the application process is to allow the Office of Clinical Research Training and Medical Education (OCRTME) at the NIH Clinical Center to evaluate applicants’ qualifications to determine applicants’ eligibility for training programs managed by the Office. Applicants must provide the required information requested in the respective applications to be considered a candidate for participation. Information submitted by candidates for training programs is reviewed initially by OCRTME administrative staff to establish eligibility for participation. Eligible candidates are then referred to the designated training program director/administrator or training program selection committee for review and decisions regarding acceptance for participation. Upon acceptance, OCRTME will collect required eligibility documents for respective training programs. A secondary objective of the application process is to track enrollment in training programs over time. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours 400. ESTIMATED ANNUALIZED BURDEN HOURS Clinical Electives Program .......................................... Pre Doctoral Students. Physicians .............. Pre Doctoral Students. Physicians .............. Pre Doctoral, PostDoctoral. Pre Doctoral Students. 300 1 20/60 100 100 200 1 1 20/60 20/60 33 67 100 200 1 1 20/60 20/60 33 67 300 1 20/60 100 ................................. ........................ 1,200 ........................ 400 Resident Electives Program ........................................ Bioethics Fellowship Program ..................................... OCRTME Onboarding Application .............................. Total ..................................................................... Dated: October 21, 2026. Frederick D. Vorck Jr., Project Clearance Liaison, NIH Clinical Center, National Institutes of Health. [FR Doc. 2026–21904 Filed 10–26–26; 8:45 am] BILLING CODE 4167–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health lotter on DSK8BHNXB4PROD with NOTICES1 Average burden per response (in hours) Type of respondents Graduate Medical Education ....................................... Medical Research Scholars Program ......................... Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. SUMMARY: The invention listed below is owned by an agency of the U.S. VerDate Sep<11>2014 17:59 Oct 26, 2026 Jkt 271001 Number of respondents Number of responses per respondent Form name Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Inquiries related to this licensing opportunity should be directed to: Jonathan Motley at 240–669–5209, or [email protected]. Licensing information may be obtained by communicating with the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852; tel. 301–496– 2644. A signed Confidential Disclosure PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Total annual burden hours Agreement will be required to receive copies of unpublished information related to the invention. SUPPLEMENTARY INFORMATION: Technology description follows: Compositions and Methods for Detecting Lymphatic Filariasis Description of Technology Lymphatic filariasis (elephantiasis; LF) is a neglected tropical disease characterized by painful deformation of the host. LF affects over 120 million people throughout the tropics and subtropics of Asia, Africa, the Western Pacific, and parts of the Caribbean and South America. LF results from infection with the filarial parasites Wuchereria bancrofti or Brugia malayi. Current methods of confirming active E:\FR\FM\27OCN1.SGM 27OCN1